Global Neurotechnology market accounted to $XX billion in 2021 to an estimated value of $XX billion in 2029, growing at a CAGR of xx% during the forecast period of 2022 to 2029.
The Neurotechnology market is expected to expand during the forecast period due to:-
Ø Increase in the geriatric population
Ø Rising prevalence of neurological conditions
Ø Increase in investment in technology
During the projected period between 2022 to 2029, the Neurotechnology market is estimated to grow at a CAGR of XX%.
High influencing factors, such as ongoing brain mapping research and investigation projects, neurotechnology-based initiatives by government bodies, and technological advances in tools and algorithms that are implemented in the neurotechnology space, are expected to propel market growth. These factors are anticipated to bolster revenue generation by spurring product adoption in this market throughout the forecast year.
Presence of organizations & institutes, such as NIH, NeuroScience Canada, University of Utah, Max Planck Florida Institute, Ontario Brain Institute, and the University of Pennsylvania; in the space is expected to majorly impact the development of neuroscience arena. These entities play a pivotal role in accelerating neuroscience-based research and development to improve patient outcomes in those suffering from neurological disorders.
Moreover, considerable government funding for the continuation of research is expected to keep the market stable and over the forecast period it is expected that novel product development from ongoing R&D will further the growth of this market.